Allink Biotherapeutics raised $42M in a Series A funding led by Lanchi Ventures to advance global clinical development of its lead candidates and expand its global footprint.
Amount Raised
$42 Million
Round Type
Series A
ShanghaiBiotechnologyHealth CareInvestors
Description
Allink Biotherapeutics, a Beijing-based clinical-stage biotechnology company, raised $42M in Series A funding. The funds will be used to advance global clinical development and enhance its portfolio in oncology and immunology.
Quick answer
Allink Biotherapeutics raised $42 Million in a Series A round, dated November 29, 2024. Investors: Med Fine Capital, Gaorong Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment and Lanchi Ventures. Allink Biotherapeutics is based in Shanghai, Shanghai, China.
- How much did Allink Biotherapeutics raise?
- Allink Biotherapeutics raised $42 Million in a Series A round on November 29, 2024.
- Who invested in Allink Biotherapeutics?
- Med Fine Capital, Gaorong Ventures, Yuanbio Venture Capital, Legend Capital, C&D Emerging Industry Equity Investment and Lanchi Ventures are named as investors in this round.
- What does Allink Biotherapeutics do?
- AllinkBio is a clinical stage biotechnology company leveraging its innovative proprietary platforms in bispecific antibodies and ADCs to develop a diverse pipeline of First-in-Class (FIC) and Best-in-Class (BIC)..
- Where is Allink Biotherapeutics based and how big is it?
- Allink Biotherapeutics is based in Shanghai, Shanghai, China.
- Who are the decision-makers at Allink Biotherapeutics?
- Fundz holds 1 contact at Allink Biotherapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Allink Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Caidya raised $165M (Private Equity) on January 13, 2025.
- Robeauté raised $28M (Series A) on January 13, 2025.
- Cornerstone Robotics raised $70M (Series C) on January 13, 2025.
- Neumirna Therapeutics raised $20M (Series A) on January 13, 2025.
- First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
- Pi Health raised $29K on January 13, 2025.
Who to call at Allink Biotherapeutics, and when
A new round usually means Allink Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Allink Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Allink Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Allink Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Allink Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAllink Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.